Aptamer Group develops custom affinity binders for use across the life sciences using its proprietary Optimer® platform. Optimer binders can be used as antibody alternatives to offer novel or improved solutions in downstream affinity purification and QC assays to support product release. Optimer binders are removing the barriers to innovation in the life sciences by offering simple resin compatibility, tuneable binding kinetics and high stability. https://aptamergroup.com/